Although universal vaccination is one of the most important healthcare strategies for limiting
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) circulation and averting the …

Several studies have described the long-term kinetics of anti-SARS-CoV-2 antibodies but
long-term follow-up data, ie,> 6 months, are still sparse. Additionally, the literature is …

Abstract Objectives Coronavirus disease-19 (COVID-19) pandemic became the greatest
public health challenge globally. Study of dynamicity and durability of naturally developed …

Objectives Circulating antibodies are important markers of previous infection and immunity.
Questions remain with respect to the durability and functionality of SARS‐CoV‐2 antibodies …

Mucosal surfaces constitute the frontiers of the body and are the biggest barriers of our body
for the outside world. Immunoglobulin A (IgA) is the most abundant antibody class present at …

The SARS-CoV-2 pandemic is underway and millions of people have been infected. A large
number of patients with COVID-19 have recovered and been discharged. While a number of …

The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with
the Delta variant fast becoming dominant across Europe. A thorough assessment of their …

In the year since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and with understanding of the etiology of the coronavirus disease 2019 (COVID-19) …

Determination of SARS-CoV-2 antibody responses in the context of pre-existing immunity to
circulating human coronavirus (HCoV) is critical for understanding protective immunity. Here …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has triggered a global health
emergency and brought disaster to humans. Tremendous efforts have been made to control …